SURG Straddle Strategy
SURG (SurgePays, Inc.), in the Technology sector, (Software - Application industry), listed on NASDAQ.
SurgePays, Inc. operates as a financial technology and telecommunications enterprise dedicated to serving the underbanked communities across the United States. A core component of its strategy is a blockchain-powered platform that transforms local corner stores and bodegas into vital technology hubs, providing a suite of financial and prepaid products. In its telecommunications division, the company delivers voice and SMS messaging services to subsidized, direct retail prepaid, and low-income subscribers. Furthermore, it offers subsidized mobile broadband connectivity to consumers in California, Colorado, Florida, Illinois, Maryland, Mississippi, Missouri, Nevada, New Jersey, Ohio, Oklahoma, Rhode Island, Tennessee, and Texas, alongside traditional prepaid wireless options. Beyond these primary offerings, SurgePays also extends specialized services to law firms in the mass tort industry, including marketing business intelligence, plaintiff generation, and caseload management solutions. To support its diverse operations, the company maintains a bilingual operations center that provides essential internal functions such as sales assistance, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, and lead generation.
SURG (SurgePays, Inc.) trades in the Technology sector, specifically Software - Application, with a market capitalization of approximately $7.8M, a beta of 0.20 versus the broader market, a 52-week range of 0.37-3.45, average daily share volume of 373K, a public-listing history dating back to 2018, approximately 130 full-time employees. These structural characteristics shape how SURG stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.20 indicates SURG has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a straddle on SURG?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current SURG snapshot
As of June 30, 2026, spot at $0.39, ATM IV 17.50%, IV rank 0.00%, expected move 5.02%. The straddle on SURG below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this straddle structure on SURG specifically: SURG IV at 17.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a SURG straddle, with a market-implied 1-standard-deviation move of approximately 5.02% (roughly $0.02 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SURG expiries trade a higher absolute premium for lower per-day decay. Position sizing on SURG should anchor to the underlying notional of $0.39 per share and to the trader's directional view on SURG stock.
SURG straddle setup
The SURG straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SURG near $0.39, the first option leg uses a $0.39 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SURG chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SURG shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.39 | N/A |
| Buy 1 | Put | $0.39 | N/A |
SURG straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
SURG straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on SURG. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on SURG
Straddles on SURG are pure-volatility plays that profit from large moves in either direction; traders typically buy SURG straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
SURG thesis for this straddle
The market-implied 1-standard-deviation range for SURG extends from approximately $0.37 on the downside to $0.41 on the upside. A SURG long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current SURG IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SURG at 17.50%. As a Technology name, SURG options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SURG-specific events.
SURG straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SURG positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SURG alongside the broader basket even when SURG-specific fundamentals are unchanged. Always rebuild the position from current SURG chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on SURG?
- A straddle on SURG is the straddle strategy applied to SURG (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With SURG stock trading near $0.39, the strikes shown on this page are snapped to the nearest listed SURG chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SURG straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the SURG straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 17.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SURG straddle?
- The breakeven for the SURG straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SURG market-implied 1-standard-deviation expected move is approximately 5.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on SURG?
- Straddles on SURG are pure-volatility plays that profit from large moves in either direction; traders typically buy SURG straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current SURG implied volatility affect this straddle?
- SURG ATM IV is at 17.50% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.